Skip to main content

February 2021

CORP 2021 - 017 - Translation and interpreting spending information at Velindre University NHS Trust
04/05/2021
 CORP 2021 - 017 - Translation and interpreting spending information at Velindre University NHS Trust (Word, 1.2Mb)

1. How much did your organisation spend on translation services (written) in the financial years 2015/2016, 2016/2017, 2017/2018, 2018/2019 and 2019/2020?

2. How much did your organisation spend on interpreting services (oral) in the financial years 2015/2016, 2016/2017, 2017/2018, 2018/2019 and 2019/2020?

For the above questions (question 1 + question 2), if your records give a total figure for translation and interpreting and you cannot give separate figures, please mention this in your reply.

For the interpreting spending (question 2), please mention whether it includes or excludes British Sign Language (BSL). Ideally, I would prefer the spending without BSL, but do let me know what data you can provide.

3. What languages were covered by the above spendings? Just to clarify, I do not need a breakdown of costs per language, just a list of languages that you had requests for over those five years.
 

4. What was the total Expenditure Budget (including financing) of your organisation for each of those financial years? It is probably something like a few hundred million pounds per annum.

CORP 2021 - 017 - Translation and interpreting spending information at Velindre University NHS Trust FOLLOW UP RESPONSE
04/05/2021
 CORP 2021 - 017 - Translation and interpreting spending information at Velindre University NHS Trust FOLLOW UP RESPONSE (Word, 1.2Mb)

Translation and interpreting spending information at Velindre University NHS Trust FOLLOW UP RESPONSE

Corp2021 019 Drug treatments at Velindre NHS Trust
10/02/2021
 Corp2021 019 Drug treatments at Velindre NHS Trust (Word, 1.3Mb)

I am analysing the treatment of lung cancer and would greatly appreciate if you could answer the following questions:

Q1. Could you please provide the total number of patients with any treatment in the last three months for:
•    Total non-small cell lung cancer (NSCLC)
•    BRAF+ non-small cell lung cancer (NSCLC)

Q2. In the past 3 months, how many non-small cell lung cancer (NSCLC) patients were treated with:
•    Afatinib
•    Alectinib 
•    Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel
•    Atezolizumab monotherapy
•    Bevacizumab 
•    Brigatinib
•    Ceritinib 
•    Crizotinib
•    Dacomitinib 
•    Dabrafenib with Trametinib
•    Docetaxel monotherapy
•    Durvalumab 
•    Erlotinib 
•    Gefitinib 
•    Gemcitabine 
•    Nintedanib with Docetaxel
•    Nivolumab
•    Osimertinib
•    Paclitaxel 
•    Pembrolizumab chemo in combination
•    Pembrolizumab monotherapy
•    Pemetrexed with Carboplatin
•    Pemetrexed with Cisplatin
•    Vinorelbine and cisplatin/carboplatin
 

CORP 2021 - 020 Annual spend with Agency on Non Clinical/Non Medical temporary staffing spreadsheet
20/04/2021
 CORP 2021 - 020 Annual spend with Agency on Non Clinical/Non Medical temporary staffing spreadsheet (Excel, 35Kb)

Annual spend with Agency on Non Clinical/Non Medical temporary staffing spreadsheet

CORP 2021 - 020 Annual spend with Agency on Non Clinical/Non Medical temporary staffing
20/04/2021
 CORP 2021 - 020 Annual spend with Agency on Non Clinical/Non Medical temporary staffing (Word, 1.3Mb)

Details of the Annual spend with Agency on Non clinical and Non Medical temporary staff.

CORP 2021 - 021 - Emrts service used at Velindre University NHS Trust
04/05/2021
 CORP 2021 - 021 - Emrts service used at Velindre University NHS Trust (Word, 1.3Mb)

"Our approach, based on a more integrated care model with the development of Velindre units in other hospitals to support planned and acute care, has also been subject to regular scrutiny and independent review.
The clinical lead in an external review of the project, carried out in 2017, was Dr Jane Barrett OBE, an eminent UK clinical oncologist and past President of the Royal College of Radiologists.” 
Can you forward Dr Barrett’s review, that is mentioned above, to me please?

 

A further quote from Velindre University NHS Trust "We treat tens of thousands of patients at the cancer centre every year and fewer than thirty patients a year on average need an unplanned emergency transfer.
Of these thirty patients, fewer than ten patients a year are critically unwell and have access to the Emergency Medical Retrieval and Transfer than three miles away and can be reached within minutes.” 
Other documents make reference to a “formal agreement” with EMRTS.
Can you please forward a copy of the formal agreement with EMRTS to me please?

How often have the staff of Velindre University NHS Trust contacted EMRTS since the service’s launch? 
How often has a FULL EMRTS response (Vehicle / Helicopter, CCP, and Doctor) attended a patient within the Velindre Centre, and dates of attendance, Please? 

Can any policies, documents, procedures, and any other relevant material concerning referring patients to EMRTS be forwarded please.

Can you forward any PRESENT policies, documents, procedures, and any other relevant material concerning the recognition, management, referral and transfer of deteriorating patients please? 

CORP 2021 - 021 - Emrts service used at Velindre University NHS Trust - DATA DOC 1
04/05/2021
 CORP 2021 - 021 - Emrts service used at Velindre University NHS Trust - DATA DOC 1 (PDF, 694Kb)

Emrts service used at Velindre University NHS Trust - DATA DOC 1

CORP 2021 - 021 - Emrts service used at Velindre University NHS Trust - DATA DOC 2
04/05/2021
 CORP 2021 - 021 - Emrts service used at Velindre University NHS Trust - DATA DOC 2 (Word, 2.2Mb)

Emrts service used at Velindre University NHS Trust - DATA DOC 2

CORP 2021 - 022 - Hospital Death Certification Costs at Velindre University NHS Trust
04/05/2021
 CORP 2021 - 022 - Hospital Death Certification Costs at Velindre University NHS Trust (Word, 1.3Mb)

Please will you provide details of costs associated with issuing Death Certificates for inpatient deaths leading to Cremation.? 
Have any changes been made to Death Certification during the Coronavirus Pandemic for NHS inpatient hospital deaths ---- please will you provide details both prior to, and following, any Coronavirus changes in the Death Certification process  
Are any NHS Hospital Medical Professionals paid in a private capacity for completing any Hospital Death Certificates, please provide details. 
Are all such private fees/payments made, accepted by the Medical Professional involved. Please can you indicate how many payments are not accepted. 
Where such payments are not accepted by the Medical Professional completing the death certificates, are the costs reduced to the family/estate of the deceased patient. 
 

CORP 2021 - 023 - Drug treatments at Velindre
04/05/2021
 CORP 2021 - 023 - Drug treatments at Velindre (Word, 1.3Mb)

I would like to check if you could assist us with the answers to the following two questions about the usage of the drug Bevacizumab:

  1. How many patients have been treated by your trust (for any medical condition) in the past 6 months with Bevacizumab? 
  2. Please provide the number of patients treated in the past 6 months with Bevacizumab for the following conditions: 
  • Colorectal cancer 
  • Breast cancer 
  • Renal cell carcinoma 
  • Non-small cell lung cancer 
  • Ovarian cancer (epithelial, fallopian tube or primary peritoneal) 
  • Carcinoma of the cervix 
     
CORP 2021 - 024 - Drug treatments at Velindre
04/05/2021
 CORP 2021 - 024 - Drug treatments at Velindre (Word, 1.3Mb)

We are analysing the incidence and treatment of Colorectal Cancer (CRC). Could you please answer for the below question;

Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?

  • Aflibercept 
  • Bevacizumab 
  • Capecitabine 
  • CAPIRI
  • CAPOX
  • Cetuximab in combination with FOLFIRI
  • Cetuximab in combination with FOLFOX
  • Cetuximab not in combination with FOLFIRI or FOLFOX
  • Irinotecan
  • FOLFIRI
  • FOLFOX
  • Oxaliplatin
  • Panitumumab in combination with FOLFIRI
  • Panitumumab in combination with FOLFOX
  • Panitumumab not in combination with FOLFIRI or FOLFOX
  • Nivolumab
  • Raltitrexed 
  • Ramucirumab 
  • Regorafenib
  • Sorafenib 
  • 5FU only
  • Tegafur Uracil + 5FU
  • Trifluridine–tipiracil 
  • XELOX
  • Other


 
 

CORP 2021 - 025 - Infuse pumps used at Velindre University NHS Trust
04/05/2021
 CORP 2021 - 025 - Infuse pumps used at Velindre University NHS Trust (Word, 1.3Mb)

Quantity, type, manufacturer, date of purchase and any information retaining to the infusion pumps used within your Hospital / Trust from 2005 to current date.

CORP 2021 - 025 - Infuse pumps used at Velindre University NHS Trust DATA
04/05/2021
 CORP 2021 - 025 - Infuse pumps used at Velindre University NHS Trust DATA (Excel, 10Kb)

Infuse pumps used at Velindre University NHS Trust DATA

CORP 2021 - 026 - Human albumin distributed by the Welsh Blood Service
04/05/2021
 CORP 2021 - 026 - Human albumin distributed by the Welsh Blood Service (Word, 1.2Mb)

I would like to submit an FOI request for the amount of human albumin in grams distributed to NHS Wales Hospitals in 2020 by Welsh Blood Service (the full calendar year), broken down by manufacturer (Bio Products Laboratory, Grifols, Biotest, CSL Behring, Octapharma, Takeda) and by concentration (4.5%, 5%, 20-25%).
Since I requested the above information about the amount of albumin distributed to NHS hospitals, could you provide me with the information on the number of vials for each of the presentations mentioned in the document you sent me?

CORP 2021 - 027 - CSA Hygiene cleaning contract held at Velindre
04/05/2021
 CORP 2021 - 027 - CSA Hygiene cleaning contract held at Velindre (Word, 1.3Mb)

Further to my record, CSA Hygiene cleaning contract has expired. Please share the latest updates.
 
Contract profile questionnaire for each type of contract:

  • Supplier/Provider of the services
  • Total Annual Spend – The spend should only relate to each of the service contracts listed above.
  • A description of the services provided under this contract please includes information if other services are included under the same Contract.
  • The number of sites the contract covers
  • The start date of the contract
  • The end date of the contract
  • The duration of the contract, please include information on any extensions period.
  • Who within the organisation is responsible for each of these contracts? name, Job Title, contact number and email address.
CORP 2021 - 027 - CSA Hygiene cleaning contract held at Velindre DATA
04/05/2021
 CORP 2021 - 027 - CSA Hygiene cleaning contract held at Velindre DATA (Excel, 14Kb)

CSA Hygiene cleaning contract held at Velindre DATA

CORP 2021 - 028 - Needle stick injuries & subcutaneous infusions at Velindre
04/05/2021
 CORP 2021 - 028 - Needle stick injuries & subcutaneous infusions at Velindre (Word, 1.3Mb)
  • In accordance to the right of information under the Freedom of Information Act 2000, we would like to request information regarding needle stick injuries and subcutaneous infusions.
  • The questions are laid out in the attached word document.
     
Velindre University NHS Trust, Unit 2,Charnwood Court, Parc Nantgarw, Nantgarw, Cardiff, CF15 7QZ
Tel: 029 2019 6161